Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Therini Bio

Therini Bio is a monoclonal Antibody.

Overview Structured Data Issues Contributors Activity

therinibio.com

Is a

Company

Organization

Company attributes

Industry

Engineering

Biomedical engineering

Biotechnology

Location

San Francisco

South San Francisco, California

CEO

‌

Michael Quigley

Pitchbook URL

pitchbook.com/profiles...268462-36

Email Address

info@therinibio.com0

Full Address

681 Gateway Blvd., Suite 411 South San Francisco, CA 94080, USA0

CIK Number

1,776,9350

Investors

Sanofi Ventures

MRL Ventures

Total Funding Amount (USD)

71,617,530

Latest Funding Round Date

April 13, 2023

Latest Funding Type

Seed

Country

United States

Other attributes

Latest Funding Round Amount (USD)

54,617,530

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Therini Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API